Introduction
============

Intestinal microbiota has a great impact on human health. These microbial populations provide crucial benefits to the host, such as metabolic activities that promote energy harvest and nutrient absorption from food, development of the host immune system, and prevention of gut colonization and infection by pathogens ([@B40]; [@B17]; [@B29]). Disturbances in microbiota composition can contribute to the development of diverse pathologies ([@B5]). Recent metagenomics studies have revealed certain microbial profiles (dysbiosis) associated with inflammatory, metabolic or infectious diseases ([@B32]; [@B44]; [@B49]). Manipulation of gut microbiota through diet, probiotics and other approaches is a promising therapeutic strategy to prevent or alleviate disorders correlated with imbalances in the intestinal microbiota ([@B50]; [@B16]).

The intestinal ecosystem is characterized by dynamic and reciprocal interactions between the microbiota, the epithelium and the mucosal immune system. This process requires elaborated regulatory mechanisms to ensure symbiosis and prevent aberrant responses that lead to pathological states. The epithelial layer is the first line of defense against pathogens and is also the surface where the host interacts with the microbiota. Epithelial cells have a critical role in sensing intestinal bacteria. They are equipped with a great variety of receptors that can recognize specific conserved molecular patterns in microbes pattern-recognition receptors (PRRs), such as the membrane-bound toll-like receptors (TLRs). TLRs mainly signal through the adaptor protein MyD88 to activate master transcription factors like NF-kappa B, thus triggering cytokine secretion and activation of host defense mechanisms. Other signaling PRRs are the cytosolic NOD-like receptors, which can modulate apoptosis and inflammatory responses ([@B22]; [@B56]; [@B9]). However, the gut microbiota does not directly interact with the intestinal epithelium. Both cell types are physically separated by the mucus layer. Commensal microbiota resides in the outer mucus layer, whereas the inner mucin layer is highly compacted and prevents bacteria from accessing the epithelial cells ([@B24]; [@B58]). In this scenario, a key issue is how the crosstalk between microbiota and the host is established. Proteins or factors secreted by microbiota have a relevant role in intestinal communication as they can diffuse through the mucin layer and come into contact with the intestinal mucosa cells.

All bacteria release extracellular vesicles as a means of communication with the environment. The best characterized are the outer membrane vesicles (OMVs) produced by Gram-negative bacteria. These vesicles act as a bacterial secretion pathway for selected proteins and other active compounds in a protected environment. In addition, they allow cell--cell communication, without direct intercellular contact ([@B31]; [@B28]). Many studies conducted in the last decade with Gram-negative pathogens showed that OMVs are internalized in the host cell and contribute to virulence by delivering cytotoxic factors, as well as mediators that interfere with the immune system ([@B14]; [@B10]; [@B47]). At present, microbiota vesicles are seen as key players in signaling processes in the intestinal mucosa ([@B26]; [@B42]). However, studies in this field are still very scarce and mainly focused on *Bacteroides fragilis* ([@B51]; [@B54]), a main Gram-negative group in the gastrointestinal tract of mammals. OMVs from this commensal promote immunomodulatory effects and prevent experimental colitis in mice. These effects are mediated by the capsular polysaccharide A (PSA) through TLR-2. However, a transcriptomic analysis in dendritic cells stimulated with *B. fragilis* ΔPSA-OMVs revealed changes in gene expression that are PSA-independent ([@B51]). *Akkermansia muciniphila* OMVs are also able to protect the progression of experimental-induced colitis in mice ([@B25]). Regarding Gram-positive bacteria, studies performed with *Bifidobacterium bifidum* LMG13195 showed that membrane vesicles from this probiotic can activate the maturation of dendritic cells, which trigger the regulatory T cells (Treg) response ([@B35]).

Our group reported the first vesicular proteome of a probiotic strain, namely *Escherichia coli* Nissle 1917 (EcN) ([@B1]). This proteomic study identified 192 vesicular proteins that have functions related to adhesion, immune modulation or bacterial survival in host niches, thus indicating that probiotic-derived OMVs contain proteins that can target these vesicles to the host and mediate their beneficial effects on intestinal function ([@B1]). EcN is a Gram-negative probiotic used in the treatment of intestinal disorders, especially in the maintenance of ulcerative colitis ([@B30]; [@B11]). The strain, which was originally isolated from a soldier who survived a severe outbreak of diarrhea during the First World War, is a good colonizer of the human gut and positively affects gastrointestinal homeostasis and microbiota balance. It is known that EcN modulates the expression of antimicrobial peptides and the immune system function in the gut by expressing bacterial factors that specifically interact with host TLRs ([@B20]).

The EcN-mediated effects have been evidenced from a great variety of *in vitro* and *in vivo* experiments performed essentially with live probiotic suspensions ([@B55]; [@B48]; [@B57]; [@B63]; [@B3]). The aim of this study was to define whether the immune modulation effects promoted by EcN are mediated through released OMVs. We extended the analysis to other commensal *E. coli* strains without probiotic traits, such as ECOR12. We analyzed the modulation of the cytokine/chemokine response by epithelial and immune cells upon stimulation with OMVs isolated from these strains in different *in vitro* and *ex vivo* models. We provide evidence that OMVs are internalized in polarized Caco-2 cells, and that these activated cells trigger an immune response in the underlying immunocompetent cells. *Ex vivo* experiments performed with colonic mucosa explants confirmed the role of OMVs in microbiota-gut signaling processes.

Materials and Methods {#s1}
=====================

Bacterial Strains and Growth Conditions
---------------------------------------

The probiotic strain EcN (serotype O6:K5:H1) was provided by Ardeypharm (GmbH, Herdecke, Germany). ECOR12 is a commensal *E. coli* strain isolated from a healthy human stool sample ([@B41]). Bacterial cells were grown at 37°C in Luria-Bertani broth (LB). Growth was monitored by measuring the optical density at 600 nm.

Preparation of Bacterial Cell Lysates and OMVs
----------------------------------------------

Bacterial lysates were prepared from cells grown in LB medium. Bacteria were collected by centrifugation (5,000 *× g*, 10 min, 4°C) and resuspended in phosphate buffer saline (PBS) for sonic disruption on ice. Cell debris was removed by centrifugation at 16,000 *× g* for 30 min at 4°C and the supernatant filtered through a 0.22 μm-pore-size filter to remove any residual cell.

Outer membrane vesicles were isolated from culture supernatants as described previously ([@B1]). In brief, bacterial cells grown overnight in LB were pelleted by centrifugation (10,000 × *g*, 20 min, 4°C); the supernatants were filtered through a 0.22 μm-pore-size filter (Millipore), concentrated by centrifugation in a Centricon Plus-70 filter device (Millipore) followed by an additional filtration step. Vesicles were then collected by centrifugation at 150,000 × *g* for 1 h at 4°C, washed and resuspended in PBS. Isolated OMVs were examined by transmission electron microscopy after negative staining as described previously ([@B13]).

Samples, either lysates or OMVs, were stored at -20°C until use. Sterility of samples was assessed on LB plates. Protein concentration was determined by the method of [@B36].

Immunoblotting of Lipopolysaccharide (LPS)
------------------------------------------

Protein samples (bacterial lysates and OMVs) were separated on 15% SDS-PAGE and transferred to a Hybond-P polyvinylidene difluoride membrane by using a Bio-Rad MiniTransblot apparatus. The membrane was blocked in PBS-0.05% Tween-20 and 5% skimmed milk (blocking solution) for 1 h at room temperature, and then incubated with specific antibodies against LPS (Abcam; 1:5,000 dilution in blocking solution) for 16 h at 4°C. The secondary antibody was donkey anti-rabbit immunoglobulin horseradish peroxidase-linked, diluted 1:15,000 in blocking solution. The protein-antibody complex was visualized by using the ECL Plus Western blotting detection system (Amersham Pharmacia Biotech).

Cell Lines and Growth Conditions
--------------------------------

Caco-2 human colon adenocarcinoma cells (ATCC HTB-37) were obtained from the American Type Culture Collection. Cells (passages 55--65) were routinely grown at 37°C in a 5% CO~2~ atmosphere in Dulbecco's modified eagle medium (DMEM) High Glucose containing 25 mM HEPES, 1% non-essential amino acids, 10% heat inactivated fetal calf serum (FCS) (Gibco BRL), penicillin G (100 U/ml) and streptomycin (100 μg/ml; Gibco BRL).

For Transwell cultures, 5 × 10^5^ Caco-2 cells were seeded on the apical compartment of 12 mm polycarbonate inserts (0.4 μm, Transwell Corning) and experiments were performed when confluent monolayers were fully polarized (18--20 days post-confluence). During growth and differentiation the medium was changed every 2 days in both compartments. Monolayer integrity was controlled by measurement of the transepithelial electrical resistance with a Millicell-ERS-2 volt-ohmmeter (Millipore, Madrid, Spain) and by visual assessment of cell layer integrity under the microscope. Prior to apical stimulation with OMVs or bacterial lysates, the medium was changed to DMEM High Glucose containing 25 mM HEPES, 1% non-essential amino acids, 1% heat inactivated FCS and gentamycin (150 μg/ml). For co-culture experiments, human peripheral blood mononuclear cells (PBMCs) were added to the basolateral compartment at a cell density of 2 × 10^6^ cells/ml.

PBMCs Isolation
---------------

Peripheral blood mononuclear cells were isolated from fresh buffy coats of six healthy donors, provided by the "Banc de Sang i Teixits" of Barcelona according to the signed agreement with the Institution. Briefly, the buffy coat was centrifuged over a Hystopaque density gradient (Hystopaque-1077, Sigma Aldrich) following the manufacturer's instructions. PBMCs were suspended in DMEM High Glucose containing 25 mM HEPES, non-essential amino acids, 1% heat inactivated FCS and gentamycin (150 μg/ml) and adjusted to 2 × 10^6^ cells/ml. Stimulation with OMVs or bacterial lysates was performed in 24 well plates (PBMCs only) or in 12 mm Transwell inserts (Caco-2/PBMCs co-culture).

Organ Culture of Human Colonic Mucosa
-------------------------------------

Macroscopically normal colonic tissue was obtained after adenocarcinoma surgery from six patients undergoing right colon resection. Full-thickness colonic wall specimens distant from the tumor and without macroscopic lesions were rinsed under a saline jet and washed twice in sterile saline at 4°C. Mucosal samples weighing 25--35 mg each were separated from underlying tissue and placed with the epithelial surface facing up on culture filter plates (15-mm diameter wells with 500-μm bottom mesh, Netwell culture systems, Costar). Filters were suspended over wells containing 1.5 ml of medium RPMI 1640 (Life Technologies) supplemented with 2 mM glutamine and 150 μg/ml gentamicin. Tissues were incubated during 5 h at 37°C in humidified atmosphere and stimulated by the addition of OMVs or bacterial lysates, as described below. During this time oxygen supply was provided to preserve tissue integrity (95% O~2~/5% CO~2~). Tissue viability was assessed by measuring lactate dehydrogenase as described elsewhere ([@B8]).

Stimulation Conditions
----------------------

To investigate the interaction between OMVs and cells of the intestinal mucosa, three different experimental approaches were performed: (i) direct stimulation of PBMCs (2 × 10^6^ cells/ml), (ii) apical stimulation of differentiated Caco-2/PBMCs co-cultures and (iii) apical stimulation of colonic mucosa explants. Each experiment was conducted six times (six individual donors in duplicate). Stimulations were performed with OMVs (50 μg/ml) or bacterial lysates (100 ng/ml) from EcN or ECOR12 strains. The concentration of these bacterial samples was selected according to experimental procedures reported elsewhere ([@B46]; [@B19]). Cells were incubated at 37°C in a 5% CO~2~ atmosphere for 5 h (for expression analysis by RT-qPCR) or 24 h (for quantification of secreted cytokines). Incubation in growth medium was performed in parallel as a control. For RNA isolation the medium was removed and cells or tissue explants were suspended in appropriate volume of *RNA later^®^* (Ambion) to preserve RNA integrity and kept at -80°C until RNA extraction. For cytokine quantification, culture supernatants were collected from direct stimulated PBMCs or from the basolateral compartment in co-culture experiments. Supernatants were clarified by centrifugation (300 × *g*, 5 min) and stored in aliquots at -80°C until use. In the *ex vivo* experiments, both culture supernatant and tissue explants were collected and processed after 5 h stimulation.

Cytokine and Chemokine Quantification in Culture Supernatants
-------------------------------------------------------------

Secreted IL-10, TNF-α, and MIP1α were measured using a cytometric bead array system (CBA FlexSet, BD Biosciences) according to manufacturer's instructions and analyzed by flow cytometry (Gallios Beckman Coulter) in the Scientific and Technological Services of the University of Barcelona (CCiT -- UB). Measurement of IL-8 and IL-6 was performed using ELISA sets (BD Biosciences). IL-22 was quantified by ELISA using the R&D System Duo Set.

RNA Isolation and Quantitative Reverse Transcription PCR (RT-qPCR)
------------------------------------------------------------------

Total RNA was extracted from PBMCs and Caco-2 cells by using the Illustra RNAspin Mini kit (GE Healthcare) according to the manufacturer's instructions. RNeasy Mini kit (Qiagen) was used to extract total RNA from colonic tissue samples. The concentration and purity of RNA samples were assessed by the ratio of absorbance at 260 and 280 nm in a NanoDrop^®^ spectrophotometer. RNA integrity was verified by visualization of 28S and 18S rRNAs after 1% agarose/formaldehyde gel electrophoresis.

RNA (1 μg for colon explants or 350 ng for PBMCs and Caco-2 cells) was reverse transcribed using the High Capacity cDNA Reverse Transcription kit (Applied Biosystems) in a final volume of 20 μl following manufacturer's recommendations. RT-qPCR reactions were performed in a StepOne Plus PCR cycler (Applied Biosystems) by using the Taqman Gene Expression Master Mix, and the Taqman probes and primers for human IL-10, MIP1α, TNF-α, IL-6, IL-8, IL-12, IL-22, TGF-β, β-defensin-2 (hBD-2), β-defensin-1 (hBD-1) and mucin-1 (MUC1). The standard PCR program used was: one denaturation cycle for 10 min at 95°C followed by 40 cycles of 15 s at 95°C and 1 min at 60°C. A control reaction was performed in the absence of RNA. The housekeeping gene β-actin was used as a normalizing gene. Relative gene expression was calculated as fold-change compared with control and calculated by means of ΔΔCt formula.

OMVs Labeling and Internalization Assay
---------------------------------------

To monitor OMVs internalization in intestinal epithelial cells, vesicles were fluorescently labeled with rhodamine isothiocyanate B-R18 (Molecular Probes) as described elsewhere ([@B7]). OMVs purified as described above were washed with PBS, resuspended in labeling buffer (50 mM Na~2~CO~3~, 100 mM NaCl, pH 9.2) in the presence of 1 mg/ml rhodamine isothiocyanate B-R18 and incubated for 1 h at 25°C. Labeled OMVs were pelleted by centrifugation at 100,000 × *g* for 1 h at 4°C, resuspended in PBS (0.2 M NaCl) and washed twice to fully remove the unbound dye. After a final centrifugation step, the rhodamine labeled-OMVs were resuspended in PBS (0.2 M NaCl) containing a protease inhibitor cocktail (Complete Protease Inhibitor Tablet, Roche) and stored at 4°C for up to 6 weeks.

OMVs internalization assays were performed using polarized Caco-2 cells (18--20 days post-confluence) grown in 96-well plate (Corning Incorporated, Costar^®^). Prior to the assay, the medium was replaced with rhodamine B-R18-labeled OMVs (2 μg/well) suspended in DMEM medium in the absence of phenol red and FCS. Cells were incubated at 37°C and fluorescence was measured over time using a Modulus^TM^ Microplate fluorescence (Turner BioSystems; Ex 570 nm; Em 595 nm). Fluorescence intensity was normalized for fluorescence detected by labeled-OMVs in the absence of epithelial cells.

OMVs internalization was assessed by confocal fluorescence microscopy. Caco-2 cells were grown in 8-well chamber slider (ibidi) and incubated with rhodamine B-R18-labeled OMVs (2 μg) at 37°C for 1 h, and then washed with PBS. Cells were fixed with 3% paraformaldehyde, permeabilized with 0.05% saponin (Sigma Aldrich) and blocked using PBS containing 1% bovine serum albumin. Nuclei were labeled with DAPI. To visualize cell boundaries, the peripheral zonula occludens ZO-1 protein was stained using anti-ZO-1 rabbit IgG antibody (Invitrogen) and Alexa Fluor 488-conjugated goat anti-rabbit IgG (Invitrogen). Confocal microscopy was carried out using a Leica TCS SP5 laser scanning confocal spectral microscope with 63x oil immersion objective lens. Images were captured with a Nikon color camera (16 bit). Fluorescence was recorded at 405 nm (blue; DAPI), 488 nm (green; Alexa Fluor 488), and 546 nm (red; rhodamine isothiocynate B-R18). Z-stack images were taken at 0.5 μm. Images were analyzed using Fiji image processing package.

Statistical Analysis
--------------------

Statistical analysis was performed using SPSS version 20.0 software (SPSS, Inc.) and data were expressed as mean ± SEM (*n* = 6). To establish the distribution of the data, the test Kolmogorov--Smirnov was run. To assess the effect of every experimental condition compared to the other conditions, the *t*-test (normal distribution) or the Mann--Whitney *U*-test (non-normal distribution) were performed. Differences between more than two groups were assessed using one-way ANOVA followed by Tukey's test. Significant differences were established at *p* ≤ 0.05.

Ethical Approval
----------------

All the procedures involving human patients were approved by the local ethics committees (Comité Ético de Investigación Clínica, Hospital Vall d'Hebron and Comité Ético del Banc de Sang i Teixits de Barcelona). Written informed consent was obtained from all patients (CEIC: PR(AG)56/2010).

Results
=======

Comparative Protein Profile and LPS Analysis of OMVs Isolated from the Probiotic EcN and the Commensal ECOR12 Strains
---------------------------------------------------------------------------------------------------------------------

Outer membrane vesicles from EcN and ECOR12 were isolated from culture supernatants. Examination of OMVs by transmission electron microscopy revealed that both strains release vesicles ranging from 20 to 60 nm in diameter (**Figure [1A](#F1){ref-type="fig"}**). To further compare the OMVs isolated from these strains, their protein profile was analyzed by SDS-PAGE and the LPS content was estimated by immunoblotting. Results showed similar protein profiles and LPS amount in both strain vesicles (**Figures [1B,C](#F1){ref-type="fig"}**). Immunoblotting of the LPS was also carried out in EcN and ECOR12 lysates (**Figure [1C](#F1){ref-type="fig"}**).

![**Analysis of EcN and ECOR12 OMVs. (A)** Negative staining electron microscopy of isolated vesicles. OMVs are indicated by arrowheads. Bar = 50 nm. **(B)** Comparison of the protein profile of EcN and ECOR12 OMVs. Isolated vesicles (10 μg) were separated in a 10%-SDS-PAGE gel and stained with Sypro^®^ Ruby. Molecular size markers are indicated. **(C)** Western blot analysis of LPS in OMVs (0.1 μg protein) or in bacterial lysates (10 μg protein) obtained from the indicated strains.](fmicb-07-00705-g001){#F1}

OMVs from EcN and ECOR12 Induce Cytokine Secretion in PBMCs
-----------------------------------------------------------

Human PBMCs, which include several types of immunogenic cells, were used to evaluate the immunomodulatory effects of OMVs secreted by EcN and ECOR12 strains. Direct stimulation of these immune cells can be used as an *in vitro* model of intestinal inflammation and barrier disruption.

PMBCs were stimulated by the addition of OMVs for 24 h in the presence of gentamicin. Stimulations with bacterial lysates were conducted in parallel for comparison. As illustrated in **Figure [2A](#F2){ref-type="fig"}**, OMVs and lysates from both strains induced the secretion of IL-10, MIP1α, TNF-α, IL-6, and IL-8 by PBMCs (*p* ≤ 0.05). Secretion levels of MIP1α, IL-6, and IL-8 were in the ng range. Lysates triggered greater activation than OMVs in this cell model for all the cytokines and chemokines studied. ECOR12 lysates tended to promote increased secretion levels of proinflammatory cytokines than EcN lysates, although only the results for TNF-α were statistically significant (**Figure [2A](#F2){ref-type="fig"}**).

![**Expression analyses of secreted cytokines and chemokines in PBMCs stimulated with OMVs or bacterial lysates.** PBMCs were challenged by addition of OMVs or bacterial lysates from EcN or ECOR12 strains. **(A)** Cytokine concentration in culture supernatants after 24 h stimulation. Data are expressed as mean ± SEM. **(B)** Relative gene expression levels in cells after 5 h stimulation. Data are presented as fold-change compared to untreated control cells. Statistical differences were assessed by one-way ANOVA followed by Tukey's test. ^∗^*p* ≤ 0.05, versus control cells; \#*p* ≤ 0.05, between cells treated with OMVs from EcN or ECOR12.](fmicb-07-00705-g002){#F2}

Expression of these inflammatory and immunomodulatory mediators was also analyzed by RT-qPCR after 5 h-stimulation. The results confirmed that all genes were upregulated in stimulated versus control cells (**Figure [2B](#F2){ref-type="fig"}**). Although, the changes in gene expression triggered by OMVs or lysates did not exactly match the secretion pattern of the soluble mediators released (**Figure [2A](#F2){ref-type="fig"}**), the tendency of ECOR12 lysates to produce greater cytokine activation was also apparent.

OMVs from EcN and ECOR12 Activate Cytokine Production by PBMCs in Co-culture with Caco-2 Cells
----------------------------------------------------------------------------------------------

To evaluate the crosstalk between OMVs, intestinal epithelial cells and immune cells, we used the Caco-2/PBMCs co-culture Transwell model that simulates the interaction of microbiota with the intestinal mucosa ([@B21]; [@B15]; [@B43]). In this model, signaling between epithelial and immune cells occurs through the release of soluble mediators.

Differentiated Caco-2 cells in the apical compartment were challenged with OMVs from EcN or ECOR12, and with bacterial lysates for comparison. After 24 h incubation, the level of released cytokines was measured in the basolateral compartment. Transepithelial electrical resistance was monitored before and after each experiment to ensure the intact barrier function of the monolayer. The results presented in **Figure [3A](#F3){ref-type="fig"}** show that apical stimulation with OMVs elicited increased secretion of IL-10, MIP1α, TNF-α, IL-6 and IL-8, whereas lysates from the same strains did not produce any activation effect, yielding comparable secreted levels as untreated control cells. Stimulations of Caco-2 monolayers without underlying PBMCs were performed in parallel. Analysis of cytokine secretion in the basolateral compartment showed that polarized Caco-2 cells are almost unresponsive in the absence of crosstalk with immune cells (data not shown). This finding is in accordance with results reported by other groups ([@B62]; [@B15]; [@B43]).

![**Expression analysis of secreted cytokines and chemokines in Caco2/PBMCs co-cultures apical stimulation.** The apical surface of Caco-2 monolayers was challenged by addition of OMVs or bacterial lysates from EcN or ECOR12 strains. **(A)** Cytokine concentration in culture supernatants after 24 h stimulation. Data are expressed as mean ± SEM. Relative gene expression levels in Caco-2 cells **(B)** and in PBMCs **(C)** after 5 h stimulation with OMVs. Data are presented as fold-change compared to untreated control cells. Statistical differences were assessed by the *t*-test or by the non-parametric Mann--Whitney *U*-test. ^∗^*p* ≤ 0.05, versus control cells; \#*p* ≤ 0.05, between cells treated with OMVs from EcN or ECOR12.](fmicb-07-00705-g003){#F3}

In Caco-2/PBMCs co-cultures the cytokine secretion profile was clearly different from that of PBMCs directly exposed to bacterial samples. As the Caco-2 monolayer constitutes a physical barrier to the bacterial factors, these results showed that OMVs, but not lysates, could stimulate epithelial cells, which in turn may signal to the underlying PBMCs. In this co-culture model, activation of Caco-2 cells by OMVs was corroborated by RT-qPCR analysis of the expression profile of IL-10, MIP1α, TNF-α, IL-6 and IL-8 after 5 h stimulation. OMVs promoted upregulation of all these mediators in Caco-2 cells in the apical compartment (**Figure [3B](#F3){ref-type="fig"}**). Interestingly, the comparison of data from stimulations performed with vesicles isolated from both strains revealed that OMVs from the probiotic strain EcN promoted a significantly higher increase in the expression of the anti-inflammatory cytokine IL-10 (**Figure [3B](#F3){ref-type="fig"}**).

Gene expression analysis in PBMCs collected from the basolateral compartment also revealed higher mRNA levels of these mediators than in PBMCs collected from untreated co-cultures (**Figure [3C](#F3){ref-type="fig"}**). However, due to variability in the data, the results did not reach statistical significance. In this case, the relative increased gene expression values were lower than those of PBMCs directly stimulated by OMVs. These results are consistent with the stimulation of PBMCs by soluble factors released from epithelial cells upon exposure to OMVs.

In this co-culture system, the different cellular responses to OMVs or to bacterial lysates may be attributed to specific OMV-mediated communication and signaling mechanisms in the epithelial barrier. Thus, we sought to prove that OMVs from these *E. coli* strains are internalized in differentiated Caco-2 cells. We took advantage of the properties of rhodamine isothiocyanate B-R18 fluorescent dye, whose fluorescence is quenched when intercalated into bilayer membranes at a high concentration. However, this dye fluoresces when diluted upon membrane fusion and internalization. Rhodamine B-R18-labeled OMVs applied to the apical side of differentiated Caco-2 cells produced a time-dependent increase in fluorescence. In contrast, no changes in fluorescence emission were observed in non-treated cells or samples containing only labeled-OMVs (**Figure [4A](#F4){ref-type="fig"}**). These results are compatible with OMVs uptake by intestinal epithelial cells. Internalization of OMVs by Caco-2 cells was assessed by confocal fluorescence microscopy at 1 h incubation with rhodamine B-R18-labeled OMVs. Immunostaining of the peripherally associated membrane protein ZO-1 was performed as an epithelial cell membrane marker. Results presented in **Figure [4B](#F4){ref-type="fig"}** confirmed the presence of EcN and ECOR12 OMVs in the cytoplasm of Caco-2 cells. Therefore, internalized OMVs can mediate microbiota immunomodulatory effects in the intact intestinal mucosa.

![**Outer membrane vesicles uptake by differentiated Caco-2 cells. (A)** Rhodamine B-R18-labeled OMVs from EcN or ECOR12 were applied to the apical side of polarized Caco-2 cells and fluorescence was measured over time (squares). OMVs (triangles) and cells (circles) alone were used as negative controls for background fluorescence. Statistical differences versus the for background fluorescence emitted by OMVs alone were assessed by one-way ANOVA followed by Tukey's test (^∗^*p* \< 0.05). **(B)** Visualization of internalized OMVs by fluorescence microscopy. Caco-2 cells were incubated with rhodamine B-R18 labeled OMVs for 1 h at 37°C. The cell membrane was visualized by immunostaining with antibodies against the zonula occludens ZO-1 protein followed by Alexa Fluor 488-conjugated secondary antibody (green). Nuclei were stained with DAPI (blue). Internalized rhodamine-R18 labeled OMVs are visualized in red. Bar: 20 μm.](fmicb-07-00705-g004){#F4}

OMVs from EcN and ECOR12 Modulate the Expression of Immuno-modulatory and Defense Mediators in *Ex Vivo* Colon Explants
-----------------------------------------------------------------------------------------------------------------------

In this study, the colon organ culture system was used as a closer model to the *in vivo* conditions. Gene expression levels of the selected mediators were analyzed by RT-qPCR (**Figure [5A](#F5){ref-type="fig"}**). The expression profile of the cytokines IL-10, MIP1α, TNF-α, IL-6, and IL-8 correlated well with the data obtained in the co-culture system. The corresponding genes were upregulated in colonic explants incubated with OMVs, but not in those incubated with bacterial lysates. After 5 h stimulation, statistically significant increases in the cytokine secreted levels were only observed for IL-6 and IL-8 (**Figure [5B](#F5){ref-type="fig"}**).

![**Expression levels of the indicated immunomodulatory and defense mediators in human colonic explants.** Colonic tissues were challenged for 5 h with OMVs or bacterial lysates from EcN or ECOR12 strains. **(A)** Relative mRNA levels of the indicated mediators. Data are presented as fold-change compared to untreated colon fragments. **(B)** IL-8 and IL-6 protein levels in culture supernatants. Data are presented as mean ± SEM. Statistical differences were assessed by the *t-*test. ^∗^*p* ≤ 0.05, versus control.](fmicb-07-00705-g005){#F5}

In this model, we also examined the expression of other genes related with host immunomodulatory or defense responses, including IL-12, TGF-β, IL-22, hBD-2, hBD-1, and MUC1. OMVs from either EcN or ECOR12 activated transcription of both IL-22 and the antimicrobial peptide hBD-2, while bacterial lysates failed to do so (**Figure [5A](#F5){ref-type="fig"}**). In contrast, a different expression profile was seen for the other mediators. Expression of both the proinflammatory cytokine IL-12 and TGF-β was downregulated either by OMVs or bacterial lysates. Expression of MUC1 was also significantly reduced (by nearly 40%) upon treatment with all the bacterial samples (**Figure [5A](#F5){ref-type="fig"}**). Gene encoding the antimicrobial peptide hBD-1 was not differentially expressed in any of the conditions tested (not shown).

Although, samples from both EcN and ECOR12 strains promoted the same expression profile, colonic explants stimulated with OMVs of the probiotic strain EcN showed a tendency toward better anti-inflammatory balance. The values of IL-10/IL-12 and IL-10/TNF-α mRNA ratios were higher in EcN-treated explants than in ECOR12-treated explants. These values were 2.50 ± 0.28 versus 1.86 ± 0.20 for IL-10/IL-12 and 1.08 ± 0.18 versus 0.80 ± 0.12 for IL-10/TNF-α.

Discussion
==========

In the gut, communication between microbiota and intestinal mucosa cells has to be established by soluble mediators that can diffuse through the mucin layer. Among the bacterial secreted factors, membrane vesicles have a key role in bacteria-host communication, allowing the delivery of effector molecules upon interaction and internalization into the host cells. Many studies performed in the last decade with pathogens evidenced the role of bacterial membrane vesicles as an important mechanism to deliver virulence and immunomodulatory factors to mammalian target cells. However, reports on microbiota vesicles are still scarce.

We focused our study to assess whether OMVs released by probiotic and commensal *E. coli* strains mediate immune modulation in cellular models that mimic damaged or intact intestinal epithelial barrier. To compare the OMVs activity with that of other bacterial fractions, parallel stimulations were performed with bacterial lysates. We analyzed expression of the chemokine MIP1α, the anti-inflammatory cytokine IL-10, and the pro-inflammatory cytokines IL-6, IL-8, and TNF-α. Our results show that direct stimulation with both EcN and ECOR12 OMVs triggered upregulation of all these mediators in PBMCs. In these cells, the genes regulated by EcN lysates had been identified through microarray analysis ([@B19]). The study showed that upregulation of IL-6, IL-8, and TNF-α by the probiotic strain EcN is mediated either by purified LPS or lysates, whereas upregulation of IL-10 is mainly activated by components of the EcN lysate that are not yet identified ([@B19]). Accordingly, the presence of LPS in *E. coli* OMVs may explain the activation of the expression of IL-6, IL-8, and TNF-α, but upregulation of IL-10 by OMVs may be attributed to another vesicle factor. In this context, it should be stressed that EcN OMVs contain some proteins known to modulate the host immune response, such as the flagellar components FlgE and FlgK, and the cytoplasmic moonlighting proteins glyceraldehyde-3-phosphate dehydrogenase and enolase ([@B1]). These moonlighting proteins can switch between different functions, depending on the cell location. Besides their basic metabolic function, when secreted, these proteins fulfill functions that enable bacteria to colonize and modulate the host immune response. As presented above, cytokine secretion levels were lower in PBMCs exposed to OMVs than in cells exposed to bacterial lysates. The greatest difference was observed for IL-10. For this anti-inflammatory cytokine, the secretion levels were more than 10-fold higher in cells challenged with bacterial lysates, whereas the relative mRNA levels were similar for both OMV and lysate-stimulated cells. According to the molecular composition, we could speculate that bacterial lysates and OMVs activate different signaling pathways or post-transcriptional regulatory mechanisms that would account for the different cytokine secreted levels after 24 h incubation.

The profile of cytokine production by PBMCs incubated with microbiota lysates was clearly different from the profile of cytokine secretion in the co-culture model, in which the epithelial barrier formed by differentiated Caco-2 cells prevent direct access of the effector molecules to underlying PBMCs. In this model, secretion of the analyzed cytokines did not increase over the control levels when the co-culture was apically stimulated with bacterial lysates. Thus, intestinal epithelial cells were poorly responsive to lysate components, which are mainly enriched with cytoplasmic proteins and factors. In contrast, OMVs elicited an immune response in the epithelial cell monolayer as shown by the increased gene expression levels of all the cytokines and chemokines analyzed. This is compatible with the presence in *E. coli* OMVs of PPR-ligands, such as LPS (TLR-4 ligand) or peptidoglycan (NOD-1/NOD-2 ligand) that can trigger NF-kappa B activation. Here, we have shown that microbiota *E. coli* OMVs are internalized in differentiated Caco-2 cells. Therefore, vesicle uptake can assist the delivery of specific bacterial ligands to cytosolic NOD-like receptors. In this co-culture model, activation of the underlying PBMCs upon apical stimulation by microbiota OMVs was assessed by RT-qPCR. Although, the relative gene expression values were not statistically significant after 5 h incubation, the mRNA levels were manifestly higher in co-cultures challenged with OMVs than in non-treated cultures. Upregulation and increased secretion of IL-10, TNF-α, and IL-6 was also described in a co-culture model of intestinal epithelial cells and dendritic cells after apical stimulation with EcN bacterial cells ([@B62]). Our results prove that PBMCs are stimulated by soluble factors released from epithelial cells upon exposure to OMVs, and show for the first time the ability of microbiota vesicles to mediate signaling events through the intestinal epithelial barrier.

The role of commensal and probiotic *E. coli* OMVs as modulators of the intestinal homeostasis and immunity was corroborated in the *ex vivo* model of colon organ culture, which is closer to the *in vivo* conditions. As in the co-culture model, upregulation of MIP1α, IL-10, TNF-α, IL-6, and IL-8 in colonic mucosa explants was only observed in samples exposed to OMVs. These vesicles also promoted upregulation of the antimicrobial peptide hBD-2. Epithelial hBD-2 plays an important role in intestinal barrier function and many probiotics can induce its secretion ([@B61]; [@B37]). Induction of the expression of hBD-2 by EcN depends on flagella synthesis, as EcN mutants with deletions in genes *fliC* or *flgE* fail to induce this antimicrobial peptide ([@B48]). Interestingly, not all *E. coli* strains activate hBD-2 expression ([@B61]; [@B37]). Our results show that OMVs from both EcN and ECOR12 promote hBD-2 upregulation, with higher relative expression levels in colonic fragments challenged with the probiotic OMVs. Induction may be mediated by flagella-associated proteins present in EcN OMVs, such as FliC or FlgE ([@B1]). These results provide evidence that OMVs released by commensal bacteria may also have positive impact on inducible antimicrobial defense mechanisms. In contrast, OMVs from these *E. coli* strains do not significantly modify expression of hBD-1. This antimicrobial peptide is constitutively expressed at high levels by colonic epithelial cells, and functions as a component of the host innate defenses at the mucosal surface. Our results are in accordance with the expression pattern reported for this β-defensin. In contrast to hBD-2, expression of hBD-1 is not inducible by bacterial components or inflammatory stimuli. However, certain enteric pathogens promote hBD-1 downregulation as a mechanism to overcome natural host defenses (reviewed by [@B12]).

Another cytokine upregulated in colonic explants by EcN and ECOR12 OMVs is IL-22. This cytokine is mainly expressed by immune cells and displays both pro-inflammatory and anti-inflammatory functions, depending on the tissue and the stimuli that direct its secretion. The pro-inflammatory properties are linked to its production by activated T helper 17 (Th17) cells. The IL-22 targets are typically non-hematopoietic cells, such as epithelial cells. In the intestine, the innate lymphoid cells resident in the lamina propria are a main source of IL-22. This population of cells is essential for the integration of microbiota-derived signals and the control of the adaptive immune response. IL-22 released by gut innate lymphoid cells helps to maintain the integrity of the epithelial barrier by inducing the expression of β-defensins and the production of mucin by globet cells ([@B38]). Therefore, IL-22 has a relevant role in host-microbiota homeostasis. Expression of this cytokine by innate lymphoid cells and T cells is activated by certain microbiota groups known to protect against food allergen sensitization, such as Clostridia. As a result, increased IL-22 levels reinforce the intestinal epithelial barrier, and therefore limit the access of allergens to the systemic circulation ([@B53]). Upregulation of IL-22 by OMVs from EcN and ECOR12 strongly suggest that certain commensal *E. coli* strains can confer intestinal barrier protection, and prevent aberrant responses to food components. In addition, this finding supports the role of microbiota vesicles as a mechanism to deliver regulatory signals to the immune cells resident in the intestinal mucosa.

The expression of genes encoding IL-12, TGF-β and MUC1 was reduced in colonic explants challenged with bacterial samples. Microbiota OMVs and bacterial lysates promoted significant downregulation of TGF-β and MUC1. Relative expression levels were reduced by 25 and 40%, respectively. Expression of the pro-inflammatory cytokine IL-12 was also downregulated, although to a lesser extent.

TGF-β is a pleiotropic cytokine with potent regulatory and inflammatory activities. Its effects depend on cellular and environmental factors. This mediator promotes differentiation of induced Treg cells, which secrete anti-inflammatory cytokines such as IL-10, and help to control inflammation. However, in the presence of IL-6, TGF-β can trigger differentiation of Th17 cells through induction of the transcriptional factor Runx1, promoting further inflammation ([@B45]; [@B33]). Th17 cells are especially abundant in the intestinal mucosa surfaces, where, in cooperation with Treg cells, they contribute to preserving intestinal homeostasis. Alteration in the Th17 (pro-inflammatory)/Treg (anti-inflammatory) balance toward excessive production of Th17 cells leads to the pathogenesis of inflammatory bowel diseases ([@B34]). Several probiotics favor the Treg response leading to the induction and secretion of anti-inflammatory cytokines such as IL-10 and TGF-β. Our results show that EcN and ECOR12 trigger downregulation of TGF-β expression. As the pro-inflammatory effects of TGF-β are related with the differentiation of Th17 cells, the reduction in TGF-β levels promoted by these microbiota strains may contribute to restoring the Th17/Treg balance under inflammatory conditions. This mechanism may explain the effectiveness of the probiotic EcN in the remission of ulcerative colitis ([@B30]).

MUC1 is a membrane-anchored mucin, located in the apical surface of mucosal epithelial cells. Production of this mucin by colonic epithelial cells is stimulated by IL-17 released by Th17 cells, and MUC1 in turn negatively regulates the Th17 cell responses in inflamed gut ([@B39]). In fact the MUC1 gene has been linked with susceptibility to inflammatory bowel disease ([@B2]). This mucin has been associated with barrier functions. However, different models have shown contradictory results. Deficiency of MUC1 results in increased colonic permeability and IL-17 responses in knockout mice lacking the T cell receptor ([@B39]), whereas knockdown of MUC1 in corneal epithelial cells did not modify the barrier function ([@B18]). *In vitro* studies performed in the colon adenocarcinoma cell line LS174T showed upregulation of MUC1 by probiotic strains, including EcN. However, this effect was not observed in an *in vivo* murine model ([@B4]). Similarly, analysis of MUC1 expression in mice colonized with EcN during the first week of life did not reveal any increase in the MUC1 mRNA levels when compared to the control group ([@B6]).

Interestingly, both MUC1 and TGF-β are overexpressed in several cancer types ([@B27]; [@B2]). As EcN and commensal *E. coli* strains promote downregulation of both mediators in intestinal mucosa explants, we may hypothesize that these microbiota strains could help to reduce cancer progression or to increase treatment effectiveness ([@B60]). This is especially interesting in the context of immunotherapy strategies in which the individual response to these therapies has been shown to be dependent on gut microbiota ([@B52]; [@B59]).

Conclusion
==========

Recent knowledge supports that microbiota is a source of regulatory signals that influence the development and maturation of the digestive and immune systems. Nowadays, potential clinical applications of gut microbes are foreseen. However, translation of microbiota-based drugs to human health care requires deep knowledge of the molecular mechanisms involved in microbiota-host interaction ([@B23]; [@B50]). Our study proves the ability of microbiota vesicles to mediate signaling events to the immune system through the intestinal epithelial barrier. Therefore, OMVs are an effective strategy used by beneficial bacteria of the human microbiota to communicate with intestinal mucosa cells, promoting the delivery of mediators that trigger host immune and defense responses. The *in vivo* beneficial effects of the probiotic EcN on gut homeostasis, especially modulation of the immune response and barrier function, can be mediated by released OMVs.
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